Bio Green Med Solution, Inc. (BGMS)
Score window: Apr. 15, 2025 to Apr. 14, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Jul. 31, 2025 | CORRESP | Neutral/Informational | High | The correspondence from Cyclacel Pharmaceuticals, Inc. is a formal request to the SEC for the acceleration of the effectiveness of their Registration Statement on Form S-1, which … | Read Filing EDGAR |
| Jul. 30, 2025 | CORRESP | Concern from SEC | Moderate | Bio Green Med Solution, Inc. has submitted a response to the SEC regarding comments on their Form S-1 registration statement for Cyclacel Pharmaceuticals, Inc. The SEC staff noted… | Read Filing EDGAR |
| Jul. 25, 2025 | UPLOAD | Concern from SEC | High | The SEC has reviewed the amended registration statement for Cyclacel Pharmaceuticals, Inc. and has issued a comment regarding the omission of required pro forma financial informat… | Read Filing EDGAR |
| Jul. 24, 2025 | CORRESP | Neutral/Informational | High | Cyclacel Pharmaceuticals, Inc. has submitted a request for the acceleration of the effectiveness of its Registration Statement on Form S-4, which was filed on July 24, 2025. The c… | Read Filing EDGAR |
| Jul. 24, 2025 | CORRESP | Neutral/Informational | Moderate | The correspondence from Bio Green Med Solution, Inc. addresses comments from the SEC regarding their Draft Registration Statement on Form S-1. The SEC requested clarification on w… | Read Filing EDGAR |
| Jul. 7, 2025 | UPLOAD | Concern from SEC | High | The SEC has conducted a limited review of Cyclacel Pharmaceuticals, Inc.'s draft registration statement submitted on June 27, 2025, and has issued a comment regarding the need for… | Read Filing EDGAR |
| Jun. 20, 2025 | UPLOAD | Neutral/Informational | Low | The SEC correspondence addresses Cyclacel Pharmaceuticals, Inc. regarding their Draft Registration Statement on Form S-4 submitted on June 16, 2025. The SEC indicates that they do… | Read Filing EDGAR |
| Apr. 28, 2025 | CORRESP | Neutral/Informational | Moderate | Cyclacel Pharmaceuticals, Inc. has submitted a request to the SEC for the acceleration of the effectiveness of its Registration Statement on Form S-1, which was filed on April 25,… | Read Filing EDGAR |